BeStock  
股票 › 医疗器械 › ABT

雅培 ABT

$109.93 −$3.67 (-3.23%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $109.93 0.00%
开盘$111.08
昨收$113.60
当日区间$109.81 – $111.81
成交量8.35M
市值$190.39B
市盈率(TTM)40.9
股息率2.26%

基本面

最新报告季度:Q3, ended Sep 2026

营收$13.01B+14.5% YoY
营业利润$1.36B-34.0% YoY
净利润$920.00M-44.0% YoY
摊薄每股收益$0.53-43.6% YoY
自由现金流$1.99B+28.9% YoY
经营现金流$2.49B

营收,近8个季度

$11.0BDec '24$10.4BMar '25$11.1BJun '25$11.4BSep '25$11.5BDec '25$11.2BMar '26$12.6BJun '26$13.0BSep '26

净利润,近8个季度

$9.2BDec '24$1.3BMar '25$1.8BJun '25$1.6BSep '25$1.8BDec '25$1.1BMar '26$928.0MJun '26$920.0MSep '26

各季度摊薄每股收益

5.27Dec '240.76Mar '251.01Jun '250.94Sep '251.01Dec '250.61Mar '260.53Jun '260.53Sep '26

各季度自由现金流

$2.1BSep '24$2.1BDec '24$933.0MMar '25$1.5BJun '25$2.3BSep '25$2.6BDec '25$916.0MMar '26$2.0BJun '26

年度营收

$34.6BFY20$43.1BFY21$43.7BFY22$40.1BFY23$42.0BFY24$44.3BFY25

盈利能力与资产负债表

毛利率56.9%
营业利润率13.8%
净利率9.7%
负债/资产比率52.6%
现金及投资$5.60B
总负债$32.61B
净现金(净负债)-$27.01B

营收构成

2026/Q2 季度

按业务线

  • Medical devices$5.85B 46.5%
  • Diagnostic Products$3.09B 24.6%
  • Nutritional Products$2.14B 17.0%
  • Established Pharmaceutical Products$1.50B 11.9%
  • Other$5.00M 0.0%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $13.01B $12.59B $11.16B $44.33B $11.46B
营业总收入 $13.01B $12.59B $11.16B $44.33B $11.46B
营业成本 $5.63B $5.33B $4.89B $19.32B $4.92B
毛利润 $7.39B $7.27B $6.27B $25.01B $6.54B
营业费用 $6.03B $5.58B $4.93B $16.96B $4.29B
销售及管理费用 $4.27B $4.03B $3.74B $12.33B $3.13B
研发费用 $920.00M $892.00M $767.00M $2.94B $735.00M
折旧、摊销与折耗 $841.00M $658.00M $422.00M $1.68B $422.00M
-折旧与摊销 $841.00M $658.00M $422.00M $1.68B $422.00M
营业利润 $1.36B $1.69B $1.35B $8.05B $2.25B
非经营性利息净收入(支出) -$297.00M -$299.00M -$68.00M -$185.00M -$42.00M
非经营性利息支出 $297.00M $351.00M $174.00M $493.00M $120.00M
其他收入(支出) $170.00M $130.00M $172.00M $598.00M $149.00M
证券出售收益 $6.00M -$4.00M $13.00M $50.00M $15.00M
其他非经营性收入(支出) $164.00M $134.00M $159.00M $548.00M $134.00M
税前利润 $1.23B $1.52B $1.45B $8.47B $2.36B
税费 $311.00M $596.00M $372.00M $1.94B $582.00M
净利润 $920.00M $928.00M $1.08B $6.52B $1.78B
持续经营利润 $920.00M $928.00M $1.08B $6.52B $1.78B
归属母公司净利润 $920.00M $928.00M $1.08B $6.52B $1.78B
归属普通股股东净利润 $920.00M $928.00M $1.08B $6.52B $1.78B
基本每股收益 $0.53 $0.53 $0.62 $3.73 $1.02
摊薄每股收益 $0.53 $0.53 $0.61 $3.72 $1.01
每股股息 $0.63 $0.63 $0.63 $2.36 $0.59
非经营性利息收入 – $52.00M $106.00M $308.00M $78.00M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $109.22B $110.43B $86.71B $86.71B $84.18B
流动资产合计 $24.52B $25.51B $26.00B $26.00B $24.84B
现金及现金等价物与短期投资 $5.60B $7.30B $8.94B $8.94B $7.73B
-现金及现金等价物 $5.10B $6.80B $8.52B $8.52B $7.51B
-短期投资 $499.00M $492.00M $417.00M $417.00M $222.00M
应收款 $11.60B $11.22B $10.57B $10.57B $10.40B
-应收账款 $8.60B $8.21B $7.93B $7.93B $8.14B
-其他应收款 $3.00B $3.01B $2.64B $2.64B $2.26B
存货 $7.32B $6.99B $6.49B $6.49B $6.71B
非流动资产合计 $84.70B $84.92B $60.72B $60.72B $59.34B
固定资产净值 $12.81B $12.38B $11.82B $11.82B $11.50B
-固定资产原值 $26.47B $25.74B $25.22B $25.22B $24.82B
-累计折旧 -$13.66B -$13.36B -$13.41B -$13.41B -$13.31B
投资及预付款 $1.11B $1.09B $918.00M $918.00M $951.00M
-可供出售证券 $747.00M $727.00M $597.00M $597.00M $633.00M
商誉及其他无形资产 $52.46B $53.10B $29.56B $29.56B $29.57B
-商誉 $35.24B $35.22B $24.04B $24.04B $23.97B
-其他无形资产 $17.21B $17.88B $5.53B $5.53B $5.59B
其他非流动资产 $18.32B $18.36B $18.42B $18.42B $17.32B
负债合计 $57.45B $57.73B $33.94B $33.94B $32.92B
流动负债合计 $17.81B $18.38B $16.50B $16.50B $14.58B
应付款 $6.30B $6.38B $6.59B $6.59B $5.62B
-应付账款 $4.79B $4.68B $4.24B $4.24B $4.12B
-应付税款合计 $411.00M $598.00M $569.00M $569.00M $469.00M
-应付股利 $1.09B $1.10B $1.10B $1.10B $1.03B
一年内应计费用 $8.51B $7.59B $6.88B $6.88B $7.62B
短期债务及融资租赁负债 $3.01B $4.41B $3.03B $3.03B $1.35B
-一年内到期债务 $3.01B $4.41B $3.03B $3.03B $1.35B
非流动负债合计 $39.64B $39.35B $17.45B $17.45B $18.34B
长期债务及融资租赁负债 $29.60B $29.64B $10.83B $10.83B $11.60B
-长期债务 $29.60B $29.64B $9.90B $9.90B $11.60B
其他非流动负债 $10.04B $9.71B $2.54B $2.54B $6.74B
股东权益合计 $51.76B $52.70B $52.77B $52.77B $51.26B
股东权益 $51.11B $52.06B $52.13B $52.13B $50.95B
股本 $25.50B $25.35B $25.53B $25.53B $25.41B
-普通股 $25.50B $25.35B $25.53B $25.53B $25.41B
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
留存收益 $49.79B $49.96B $49.78B $49.78B $49.10B
减:库存股 $17.97B $16.94B $17.18B $17.18B $16.88B
不影响留存收益的损益 -$6.21B -$6.31B -$6.00B -$6.00B -$6.68B
少数股东权益 $652.00M $640.00M $641.00M $641.00M $310.00M
-其他应付款 – – $682.00M $682.00M –
长期应付账款及其他应付款 – – $1.40B $1.40B –
-长期融资租赁负债 – – $931.00M $931.00M –
一年以上递延负债 – – $559.00M $559.00M –
员工福利 – – $2.13B $2.13B –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $2.49B $1.32B $9.57B $3.32B $2.79B
持续经营经营活动现金流净额 $2.49B $1.32B $9.57B $3.32B $2.79B
持续经营净利润 $928.00M $1.08B $6.52B $1.78B $1.64B
折旧、折耗与摊销 $1.06B $803.00M $3.12B $792.00M $791.00M
其他非现金项目 $1.02B -$420.00M – – $221.00M
营运资金变动 -$687.00M -$462.00M -$803.00M $110.00M $11.00M
-应收款变动 -$386.00M -$42.00M -$652.00M $222.00M -$202.00M
-存货变动 -$301.00M -$420.00M $195.00M $234.00M $213.00M
投资活动现金流净额 -$673.00M -$20.32B -$2.42B -$913.00M -$457.00M
持续经营投资活动现金流净额 -$673.00M -$20.32B -$2.42B -$913.00M -$457.00M
固定资产购置及出售净额 -$497.00M -$399.00M -$2.17B -$689.00M -$496.00M
业务购买及出售净额 -$164.00M -$19.80B -$105.00M -$20.00M -$55.00M
投资购置及出售净额 -$26.00M -$161.00M -$164.00M -$210.00M $90.00M
其他投资变动净额 $14.00M $34.00M $18.00M $6.00M $4.00M
筹资活动现金流 -$3.52B $17.31B -$6.31B -$1.40B -$1.76B
持续经营筹资活动现金流净额 -$3.52B $17.31B -$6.31B -$1.40B -$1.76B
债务发行及偿还净额 -$1.37B $18.48B -$1.61B -$70.00M -$493.00M
普通股发行净额 -$1.05B -$180.00M -$893.00M -$302.00M -$305.00M
已付现金股利 -$1.10B -$1.10B -$4.12B -$1.03B -$1.03B
股票期权行使所得 $3.00M $116.00M $396.00M $5.00M $69.00M
期末现金余额 $5.10B $6.80B $8.52B $8.52B $7.51B
现金净变动 -$1.70B -$1.70B $835.00M $1.01B $570.00M
期初现金余额 $6.80B $8.52B $7.62B $7.51B $6.95B
汇率变动影响 $4.00M -$23.00M $71.00M $6.00M -$10.00M
自由现金流 $1.99B $916.00M $7.40B $2.63B $2.29B
持续经营损益 – – $65.00M – –
-预付资产变动 – – -$1.30B – –
-应付账款及应计费用变动 – – $949.00M – –
其他筹资费用净额 – – -$82.00M $0.00 $0.00

讨论区

暂无评论——快来第一个聊聊 ABT。

登录后参与讨论。

Scroll to Top